Related Experiment Videos

Selection bias, phase II trials, and the FDA accelerated approval process

Stephen L George

Journal of the National Cancer Institute

|September 18, 2003

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Assessment of treatment effect heterogeneity for multiregional randomized clinical trials.

Statistics in biopharmaceutical research·2025

Futility monitoring for randomized clinical trials with non-proportional hazards: An optimal conditional power approach.

Clinical trials (London, England)·2023

A Signature Enrichment Design with Bayesian Adaptive Randomization.

Journal of applied statistics·2021

Design and analysis of biomarker-integrated clinical trials with adaptive threshold detection and flexible patient enrichment.

Journal of biopharmaceutical statistics·2020

Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.

Journal of biopharmaceutical statistics·2019

Auxiliary variable-enriched biomarker-stratified design.

Statistics in medicine·2018

See all related articles